[Heart pathology of extracardiac origin. VII. Heart and neoplasms].
Cardiac alterations of neoplastic diseases can be due to direct invasion produced by primary cardiac tumors or more frequently secondary to local compression of vascular structures by extracardiac neoplasms, such as superior vena cava syndrome. One of the most important alterations is the cardiotoxicity of anticancer treatments, either chemotherapy drugs or radiotherapy techniques. These treatments cause acute and/or chronic cardiotoxicity that the oncologist and the cardiologist must be aware of. For instance, 4.5% to 7% of patients that have been treated with anthracyclines may suffer cardiac failure in their lifetime. The pathogenesis is still not clear. There is currently a lot of research on cardioprotectors, but nowadays the only one approved by the FDA is dexrazoxane, which is used on breast cancer patients treated with adriamycin.
Calzas
J
J
Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid.
Lianes
P
P
Cortés-Funes
H
H
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced / Q000209:etiology*; D006338:Heart Neoplasms / Q000175:diagnosis / Q000556:secondary; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D013479:Superior Vena Cava Syndrome / Q000175:diagnosis / Q000209:etiology
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D004317:Doxorubicin
Patología del corazón de origen extracardíaco (VII). Corazón y neoplasias.